<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 30, 2018 (HealthDay News) — Primary care management of obstructive sleep apnea (OSA) is as effective and more cost-effective than in-laboratory diagnosis, according to a study published online April 17 in the American Journal of Respiratory and Critical Care Medicine<\/i>.<\/p>\n
M. \u00c1ngeles S\u00e1nchez-Quiroga, M.D., from Virgen del Puerto Hospital in Madrid, and colleagues randomized 303 sequentially screened patients with an intermediate-to-high probability of OSA to primary care management (a portable monitor with automatic scoring and semi-automatic therapeutic decision-making) or in-laboratory management (polysomnography and specialized therapeutic decision-making). All patients received continuous positive airway pressure treatment or sleep hygiene and dietary treatment alone.<\/p>\n
The researchers found that the primary care protocol was noninferior to the in-laboratory protocol based on use of the Epworth sleepiness scale. Furthermore, primary health care management was more cost-effective, with a lower cost of \u0080537.8 per patient.<\/p>\n
“Primary health care area management may be an alternative to in-laboratory management for patients with an intermediate to high OSA probability,” the authors write. “Given the clear economic advantage of outpatient management, this finding could change established clinical practice.”<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n